Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis
Journal of Thrombosis and Haemostasis2021Vol. 19(11), pp. 2801–2813
Citations Over TimeTop 10% of 2021 papers
Faizan Khan, Tobias Tritschler, Miriam Kimpton, Philip S. Wells, Clive Kearon, Jeffrey I. Weitz, Harry R. Büller, Gary E. Raskob, Walter Ageno, Françis Couturaud, Paolo Prandoni, Gualtiero Palareti, Cristina Legnani, Paul A. Kyrle, Sabine Eichinger, Lisbeth Eischer, Cecilia Becattini, Giancarlo Agnelli, Maria Cristina Vedovati, Geert‐Jan Geersing, Toshihiko Takada, Benilde Cosmi, Drahomir Aujesky, Letizia Marconi, Antonio Palla, Sergio Siragusa, Charlotte Bradbury, Sameer Parpia, Ranjeeta Mallick, Anthonie W.A. Lensing, Martin Gebel, Michael Grosso, Minggao Shi, Kednapa Thavorn, Brian Hutton, Grégoire Le Gal, Marc Rodger, Dean Fergusson
Related Papers
- → Adherence to PIOPED II Investigators' Recommendations for Computed Tomography Pulmonary Angiography(2012)75 cited
- → Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients(2012)27 cited
- → Can judgments according to case fatality rate be correct all the time during epidemics? Estimated cases based on CFR in different scenarios and some lessons from early case fatality rate of coronavirus disease 2019 in Iran(2020)7 cited
- → 3002 POSTER DISCUSSION Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: a Real-world Analysis of VTE Risk and the Impact of VTE on Healthcare Expenditure(2011)1 cited
- → 2 venous thromboembolism (VTE)Venous Thromboembolism(2020)